Related Experiment Video
Updated: Mar 5, 2026

Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer
Published on: October 13, 2023
The pulmonary nodule "discovered" by pneumonia: a case report
Dong-Mei Yuan1, Jian-Ya Zhang1, Yan-Wen Yao1
1Department of Respiratory Medicine, Jinling Hospital, Nanjing 210002, China;; Research Institute of Respiratory Disease, Nanjing University, Nanjing 210002, China.
This case report highlights the management of a lung nodule found incidentally. It suggests CT surveillance for solid nodules, using 3D CT reconstructions, and considering circulating tumor cells for malignancy clues.
Area of Science:
- Pulmonology
- Oncology
- Radiology
Background:
- Increasing incidence of pulmonary nodules detected via low-dose computed tomography (CT) screening for lung cancer.
- Clinical challenges in diagnosing pulmonary nodules and determining appropriate management strategies.
- Existing guidelines and prediction models may not fully address complex patient realities.
Observation:
- A 58-year-old male presented with an incidentally discovered lung nodule in the right upper lobe during pneumonia treatment.
- The patient underwent a two-period follow-up protocol and participated in a clinical trial for circulating tumor cells (CTCs).
- Surgical excision ultimately led to a pathological diagnosis of adenocarcinoma.
Findings:
- Computed tomography (CT) surveillance may be beneficial for solid pulmonary nodules approximately 8 mm in maximum diameter.
- Three-dimensional reconstruction of CT scans can offer enhanced visualization and detailed information about nodule characteristics.
- Peripheral blood circulating tumor cell (CTC) counts show potential as an indicator for malignancy.
Implications:
- This case underscores the importance of tailored follow-up strategies for pulmonary nodules.
- Advanced imaging techniques like 3D CT reconstruction can aid in nodule characterization.
- Circulating tumor cells (CTCs) may serve as a valuable biomarker in the diagnostic workup of lung nodules, potentially guiding treatment decisions.
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pneumonia II: Pathophysiology
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

